FrancophonIA/ELRC3.0 huggingface dataset:
English: What Trulicity is and what it is used for
Slovenian: Kaj je zdravilo Trulicity in za kaj ga uporabljamo
English: You should see a doctor immediately if you experience symptoms such as rashes, itching and rapid swelling of the tissues of the neck, face, mouth or throat, hives and difficulties breathing.
Slovenian: Takoj morate obiskati zdravnika, če se pri vas pojavijo simptomi, kot so: izpuščaj, srbečica in hitro otekanje tkiva vratu, obraza, ust ali grla, koprivnica in težave z dihanjem.
English: Cardiovascular outcome study
Slovenian: Študija kardiovaskularnih izidov
English: In contrast to native GLP-1, dulaglutide is resistant to degradation by DPP-4, and has a large size that slows absorption and reduces renal clearance.
Slovenian: Vendar pa je za razliko od naravnega GLP-1 dulaglutid stabilen proti razgradnji z DPP-4 , in ima večjo velikost, ki upočasni absorpcijo ter zmanjša ledvični očistek.
English: Inject your next dose on your regular scheduled day.
Slovenian: Svoj naslednji odmerek si injicirajte na naslednji predpisani dan.
English: Injection site adverse events were reported in 1.9 % of patients receiving dulaglutide.
Slovenian: O reakcijah na mestu injiciranja so poročali pri 1,9 % bolnikov, ki so prejemali dulaglutid.
English: Sitagliptin can produce up to 80 % inhibition of DPP-4 over a 24-hour period.
Slovenian: Sitagliptin lahko povzroči do 80% zaviranje dipeptidil-peptidaze 4 (DPP-4) v 24-urnem obdobju.
English: Do not remove the pen from your skin until you hear the second louder click.
Slovenian: Ne umaknite peresnika s kože, dokler ne slišite drugega glasnega klika.
English: Your doctor should tell you how to treat low blood sugar.
Slovenian: Vaš zdravnik vam bo razložil, kako uravnati nizek krvni sladkor.
English: • When you press the green injection button, the pen will automatically insert the needle into your skin, inject the medicine, and pull back (retract) the needle after the injection is complete.
Slovenian: • Ko pritisnete zeleni gumb za injiciranje, bo peresnik samodejno potisnil iglo v vašo kožo, injiciral zdravilo in iglo po zaključenem injiciranju potegnil nazaj.
English: Trulicity that has been frozen must not be used.
Slovenian: Zdravila Trulicity, ki je zmrznilo, ne smete uporabljati.
English: - Symptoms of low blood sugar may include headache, drowsiness, weakness, dizziness, feeling hungry, confusion, irritability, fast heartbeat and sweating.
Slovenian: - simptomi nizkega krvnega sladkorja lahko vključujejo glavobol, zaspanost, šibkost, omotico, občutek lakote, zmedenost, razdražljivost, hiter srčni utrip in potenje.
English: Manufacturer Eli Lilly Italia S.p.A.,Via Gramsci 731/733, 50019, Sesto Fiorentino, Firenze (FI), Italy
Slovenian: Proizvajalec Eli Lilly Italia S.p.A.,Via Gramsci 731/733, 50019, Sesto Fiorentino, Firenze (FI), Italija
English: This occurs when the needle starts retracting in about 5-10 seconds.
Slovenian: Do tega pride, ko se igla začne umikati, po približno 5
English: What Trulicity is and what it is used for What you need to know before you use Trulicity How to use Trulicity
Slovenian: Kaj je zdravilo Trulicity in za kaj ga uporabljamo Kaj morate vedeti, preden boste uporabili zdravilo Trulicity Kako uporabljati zdravilo Trulicity
English: What if I unlock the pen and press the green injection button before pulling off the base cap?
Slovenian: Kaj če odklenem peresnik in pritisnem zeleni gumb za injiciranje preden odstranim pokrovček z dna?
English: Continue holding the clear base firmly against your skin until you hear a second click.
Slovenian: Še naprej trdno držite prozorno podnožje na koži, dokler ne zaslišite drugega klika.
English: It is important that you test your blood glucose levels as instructed by your doctor, pharmacist or nurse, if you are taking Trulicity with a sulphonylurea or insulin.
Slovenian: Pomembno je, da redno preverjate vaše ravni glukoze v krvi kot vam je naročil zdravnik, farmacevt ali medicinska sestra, če jemljete zdravilo Trulicity s sulfonilsečnino ali z insulinom.
English: BEFORE YOU GET STARTED Remove
Slovenian: PREDEN ZAČNETE
English: Change (rotate) your injection site each week.
Slovenian: • Vsak teden spremenite (rotirajte) mesto injiciranja.
English: • When refrigeration is not possible, you can keep your syringe at room temperature
Slovenian: • Kadar shranjevanje v hladilniku ni mogoče, lahko svoj peresnik shranjujete pri sobni temperaturi (pod
English: Tell your doctor if you are pregnant, think you may be pregnant or are planning to have a baby, as Trulicity should not be used during pregnancy.
Slovenian: Če ste noseči, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom, saj zdravila Trulicity med nosečnostjo ne smete jemati.
English: This clinical study did not include patients with end stage renal disease.
Slovenian: Ta klinična študija ni vključevala bolnikov s končno ledvično odpovedjo.
English: Do not remove the base cap and do not use the pen.
Slovenian: Ne odstranjujte pokrovčka z dna in ne uporabite peresnika.
English: Consistent with the pharmacokinetic profile, dulaglutide has a pharmacodynamic profile suitable for once weekly administration (see section 5.2).
Slovenian: Skladno s farmakokinetičnim profilom ima dulaglutid farmakodinamični profil, ki je primeren za aplikacijo zdravila enkrat na teden (glejte poglavje 5.2).
English: Clinical studies with dulaglutide have indicated enhanced beta-cell function as measured by homeostasis model assessment (HOMA2-%B).
Slovenian: Klinične študije z dulaglutidom so pokazale povečano delovanje beta celic, merjeno z oceno modela homeostaze (HOMA2-%B).
English: If you want to do so, you can use the same area of your body each week.
Slovenian: Če želite, lahko vsak teden uporabite isti del telesa za injiciranje.
English: Dulaglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist.
Slovenian: Dulaglutid je dolgodelujoči receptorski agonist glukagonu podobnega peptida 1 (GLP-1).
English: The molecule consists of 2 identical disulfide-linked chains, each containing a modified human GLP-1 analogue sequence covalently linked to a modified human immunoglobulin G4 (IgG4) heavy chain fragment (Fc) by a small peptide linker.
Slovenian: Molekula je sestavljena iz 2 identičnih verig, povezanih z disulfidno vezjo, vsaka veriga pa vsebuje modificiran analogni niz humanega GLP-1, kovalentno spojen v modificirani del težke verige (Fc) področja humanega imunoglobulina G4 (IgG4) z majhno peptidno vezjo.
English: Trulicity contains an active substance called dulaglutide and is used to lower blood sugar (glucose) in adults with type 2 diabetes mellitus and can help prevent heart disease.
Slovenian: Zdravilo Trulicity vsebuje zdravilno učinkovino, imenovano dulaglutid, in se uporablja za zniževanje krvnega sladkorja (glukoze) pri odraslih s sladkorno boleznijo tipa 2 ter lahko pomaga preprečevati bolezni srca.
English: The signs include rapid weight loss, feeling sick or being sick, a sweet smell to your breath, a sweet or metallic taste in your mouth, or a different odour to your urine or sweat.
Slovenian: Znaki vključujejo hitro izgubo telesne mase, občutek slabosti ali siljenje na bruhanje, sladkoben vonj vaše sape, sladek ali kovinski okus v vaših ustih ali spremenjen vonj vašega urina ali znoja.
English: The Trulicity long-term cardiovascular outcome study was a placebo-controlled, double-blind clinical trial.
Slovenian: Dolgoročna študija kardiovaskularnih izidov z zdravilom Trulicity je bila s placebom nadzorovano, dvojno slepo klinično preskušanje.
English: Dulaglutide is associated with mean increases from baseline in pancreatic enzymes (lipase and/or pancreatic amylase) of 11 % to 21 % (see section 4.4).
Slovenian: Dulaglutid je povezan s povprečnim zvišanjem encimov trebušne slinavke od izhodišča (lipaza in/ali pankreasna amilaza) od 11 % do 21 % (glejte poglavje 4.4).
English: - you have ever had pancreatitis (inflammation of the pancreas) which causes severe pain in the stomach and back which does not go away.
Slovenian: - ste kadar koli imeli pankreatitis (vnetje trebušne slinavke), ki povzroča hudo bolečino v trebuhu in hrbtu, ki ne poneha.
English: This change is not expected to have clinical consequences.
Slovenian: Ni verjetno, da bi imela ta sprememba klinične posledice.
English: Following subcutaneous administration to patients with type 2 diabetes, dulaglutide reaches peak plasma concentrations in 48 hours.
Slovenian: Absorpcija Po subkutani aplikaciji bolnikom s sladkorno boleznijo tipa 2 dulaglutid doseže najvišje koncentracije v plazmi v 48 urah.
English: - you have diabetic ketoacidosis (a complication of diabetes that occurs when the body is unable to break down glucose because there is not enough insulin).
Slovenian: - imate diabetično ketoacidozo (zaplet sladkorne bolezni, do katerega pride, ko telo ne more razgraditi glukoze, ker nima na voljo dovolj insulina).
English: This is not unusual and will not affect your dose.
Slovenian: To ni nič neobičajnega in ne bo vplivalo na vaš odmerek.
English: - you have type 1 diabetes (the type when your body does not produce any insulin) as this medicine may not be right for you.
Slovenian: - imate sladkorno bolezen tipa 1 (tip bolezni pri kateri vaše telo sploh ne proizvaja insulina), saj to zdravilo najverjetneje ne bo pravo za vas.
English: When your injection is complete, the plunger should be pushed fully into the syringe, with no more medicine left in it.
Slovenian: Ko je injiciranje končano, mora biti bat v celoti potisnjen v injekcijsko brizgo, v kateri ni več zdravila.
English: With your other hand, hold the syringe like a pencil.
Slovenian: Z drugo roko primite injekcijsko brizgo kot svinčnik.
English: Dulaglutide significantly improved total treatment satisfaction compared to exenatide twice daily.
Slovenian: Dulaglutid je značilno izboljšal skupno zadovoljstvo z zdravljenjem v primerjavi z eksenatidom dvakrat na dan.
English: Body weight or body mass index
Slovenian: Telesna masa ali indeks telesne mase
English: In the absence of other signs and symptoms of acute pancreatitis, elevations in pancreatic enzymes alone are not predictive of acute pancreatitis.
Slovenian: Če ni drugih znakov in simptomov akutnega pankreatitisa, sama zvišanja ravni encimov trebušne slinavke ne napovedujejo akutnega pankreatitisa.
English: Patients with dulaglutide anti-drug antibodies generally had low titres, and although the number of patients developing dulaglutide anti-drug antibodies was low, examination of the phase III data revealed no clear impact of dulaglutide anti-drug antibodies on changes in HbA1c.
Slovenian: Bolniki s protitelesi proti dulaglutidu so na splošno imeli nizke titre in čeprav je bilo število bolnikov, pri katerih so se razvila protitelesa proti dulaglutidu, majhno, je pregled podatkov 3. faze razkril, da ni jasnega vpliva protiteles proti dulaglutidu na spremembe vrednosti HbA1c.
English: Statistically significant delays in lisinopril tmax of approximately 1 hour were observed on Days 3 and 24 of the study.
Slovenian: Opazili so statistično pomembne zakasnitve v tmax lisinoprila za približno 1 uro na dneva 3 in 24 študije.
English: In the presence of elevated glucose concentrations, dulaglutide increases intracellular cyclic AMP (cAMP) in pancreatic beta cells leading to insulin release.
Slovenian: Pri povečanih koncentracijah glukoze dulaglutid povečuje intracelularno ciklično AMP (cAMP) v beta celicah trebušne slinavke, s čimer povzroči sproščanje insulina.
English: Until then, store your pen safely to avoid an accidental needle stick injury.
Slovenian: Do tedaj shranite svoj peresnik na varno mesto, da boste preprečili poškodbe zaradi vboda igle.
English: Papendorpseweg 83, 3528 BJ Utrecht
Slovenian: Papendorpseweg 83, 3528 BJ UtrechtNizozemska
English: It is not known if dulaglutide passes into human breast milk.
Slovenian: Ni znano, ali dulaglutid prehaja v materino mleko.
English: - or with other medicines for diabetes when they are not enough to control your blood sugar levels.
Slovenian: - ali z drugimi zdravili za zdravljenje sladkorne bolezni, če ta ne zadoščajo za uravnavanje vaših ravni krvnega sladkorja.
English: Slowly push the plunger all the way in until all the medicine is injected.
Slovenian: Počasi potisnite bat do konca, dokler ne injicirate vsega zdravila.
English: Type 2 Diabetes Mellitus
Slovenian: Sladkorna bolezen tipa 2
English: • When refrigeration is not possible, you can keep your pen at room temperature (below 30°C) for up to a total of 14 days.
Slovenian: • Kadar shranjevanje v hladilniku ni mogoče, lahko svojo injekcijsko brizgo shranjujete pri sobni temperaturi (pod 30 °C) skupno največ 14 dni.
English: Do not use Trulicity - if you are allergic to dulaglutide or any of the other ingredients of this medicine (listed in section 6).
Slovenian: - če ste alergični na dulaglutid ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Figure 2: Forest plot of analyses of individual cardiovascular event types, all cause death, and consistency of effect across subgroups for the primary endpoint
Slovenian: Slika 2: Drevesni diagram analiz posameznih vrst kardiovaskularnih dogodkov, smrti zaradi katerega koli vzroka, in podskupin za primarni opazovani dogodek
English: Dulaglutide has not been studied in patients with severe gastrointestinal disease, including severe gastroparesis, and is therefore not recommended in these patients.
Slovenian: Uporaba dulaglutida ni bila preučena pri bolnikih s hudo boleznijo prebavil, vključno s hudo gastroparezo, zato pri teh bolnikih uporaba zdravila ni priporočljiva.
English: The durability of effect on beta-cell function was maintained through the longest study duration of 104 weeks.
Slovenian: Trajanje učinka na delovanje beta celic se je ohranilo vse do 104. tedna, kolikor je trajala najdaljša študija.
English: Therefore, the use of dulaglutide is not recommended during pregnancy.
Slovenian: Uporaba dulaglutida med nosečnostjo zato ni priporočljiva.
English: Store in a refrigerator (2ºC - 8ºC).
Slovenian: Shranjujte v hladilniku (2 ºC 8 ºC).
English: Subcutaneous use.
Slovenian: subkutana uporaba.
English: Studies characterising the pharmacokinetics of dulaglutide in paediatric patients have not been performed.
Slovenian: Pediatrična populacija Študije, ki bi ugotavljale farmakokinetiko dulaglutida pri pediatričnih bolnikih, niso bile opravljene.
English: In the phase II and phase III clinical studies, systemic hypersensitivity events (e.g., urticaria, edema) were reported in 0.5 % of patients receiving dulaglutide.
Slovenian: V kliničnih študijah 2. in 3. faze so poročali o dogodkih sistemske preobčutljivosti (npr. urtikarija, edem) pri 0,5 % bolnikov, ki so prejemali dulaglutid.
English: Not known: the frequency cannot be estimated from the available data - Bowel obstruction - a severe form of constipation with additional symptoms such as stomach ache, bloating or vomiting.
Slovenian: Neznani učinki: pogostnost ne more biti ocenjena iz razpoložljivih podatkov - Zapora črevesja - resna oblika zaprtosti z dodatnimi simptomi kot so bolečina v trebuhu,
English: Patients receiving dulaglutide in combination with sulphonylurea or insulin may have an increased risk of hypoglycaemia.
Slovenian: Pri bolnikih, ki prejemajo zdravilo dulaglutid v kombinaciji s sulfonilsečnino ali insulinom, lahko obstaja povečano tveganje za hipoglikemijo.
English: You can use your syringe at any time of the day, with or without meals.
Slovenian: Injekcijski peresnik lahko uporabljate kadar koli v dnevu, z ali brez hrane.
English: Gender and race Gender and race had no clinically meaningful effect on the pharmacokinetics of dulaglutide.
Slovenian: Spol in rasa nista imela klinično pomembnega učinka na farmakokinetiko dulaglutida.
English: METHOD AND ROUTE(S) OF ADMINISTRATION For single use only.
Slovenian: POSTOPEK IN POT(I) UPORABE ZDRAVILA Za enkratno uporabo.
English: The incidence of acute pancreatitis in Phase II and III clinical studies was 0.07% for dulaglutide compared to 0.14% for placebo and 0.19% for comparators with or without additional background antidiabetic therapy.
Slovenian: Pojavnost akutnega pankreatitisa v kliničnih študijah 2. in 3. faze je bila 0,07 % za dulaglutid v primerjavi z 0,14 % za placebo in 0,19 % za primerjalna zdravila z ali brez osnovnega antidiabetičnega zdravljenja.
English: This leaflet was last revised in Month YYYY
Slovenian: Navodilo je bilo nazadnje revidirano mesec LLLL
English: Cardiovascular Evaluation
Slovenian: Kardiovaskularna ocena
English: In the completed phase II and phase III initial registration studies, 4,006 patients were exposed to dulaglutide alone or in combination with other glucose lowering medicinal products.
Slovenian: Povzetek varnostnega profila V zaključenih začetnih registracijskih študijah 2. in 3. faze je bilo 4006 bolnikov izpostavljenih dulaglutidu samemu ali pa v kombinaciji z drugimi zdravili za znižanje glukoze.
English: Patient reported outcomes
Slovenian: Izidi, o katerih so poročali bolniki
English: You may inject the medicine into your stomach (abdomen) or thigh.
Slovenian: • Zdravilo si lahko injicirate v trebuh (abdomen) ali stegno.
English: When used with other medicines for diabetes, the recommended dose is 1.5 mg once a week.
Slovenian: Ob uporabi skupaj z drugimi zdravili za zdravljenje sladkorne bolezni je priporočeni odmerek zdravila 1,5 mg enkrat na teden.
English: Do not recycle the filled sharps container.
Slovenian: • Polnega vsebnika za ostre odpadke ne reciklirajte.
English: Check
Slovenian: Preverite
English: If you are taking a sulphonylurea or insulin, the dose may need to be lowered while you use dulaglutide.
Slovenian: Če jemljete sulfonilsečnino ali insulin, bo morda treba odmerek zmanjšati za čas, ko uporabljate dulaglutid.
English: Effects of overdose with dulaglutide in clinical studies have included gastrointestinal disorders and hypoglycaemia.
Slovenian: Učinki prevelikega odmerjanja so v kliničnih študijah z dulaglutidom vključevali gastrointestinalne motnje in hipoglikemijo.
English: These changes were not clinically relevant; therefore no dose adjustment of lisinopril or metoprolol is necessary when administered with dulaglutide.
Slovenian: Te spremembe se niso štele za klinično pomembne, zato prilagoditev odmerka lisinoprila ali metoprolola, če je to zdravilo dano sočasno z dulaglutidom, ni potrebna.
English: Because Trulicity can slow stomach emptying which could affect other medicines, tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicine.
Slovenian: Druga zdravila in zdravilo Trulicity Ker lahko zdravilo Trulicity zmanjša praznenje želodca, kar lahko vpliva na druga zdravila, obvestite zdravnika, farmacevta ali medicinsko sestro, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo.
English: Dulaglutide exhibits several antihyperglycaemic actions of GLP-1.
Slovenian: Dulaglutid kaže več antihiperglikemičnih učinkov GLP-1.
English: Dulaglutide is presumed to be degraded into its component amino acids by general protein catabolism pathways.
Slovenian: Domneva se, da se dulaglutid razgrajuje v svoje sestavne dele − aminokisline prek splošnih poti katabolizma beljakovin.
English: Within each incidence grouping, adverse reactions are presented in order of decreasing frequency.
Slovenian: V okviru razvrstitev po incidenci so neželeni učinki navedeni po padajoči pogostnosti.
English: After Week 1, patients were up-titrated to 1.2 mg/day and then at Week 2 to 1.8 mg/day.
Slovenian: Po 1. tednu so jim odmerek titrirali do 1,2 mg/dan, v 2. tednu pa do 1,8 mg/dan.
English: • If you have vision problems, DO NOT use your pen without help from a person trained to use the Trulicity pen.
Slovenian: • Če imate težave z vidom, NE uporabljajte svojega peresnika brez pomoči osebe, ki je usposobljena za uporabo peresnika Trulicity.
English: Statistically significant reductions in Cmax of 26 % and 13 % and delays in tmax of 2 and 0.30 hours were observed for norelgestromin and ethinyl estradiol, respectively.
Slovenian: Opazili pa so statistično pomembna znižanja Cmax za 26 % in 13 % ter zakasnitvi tmax za 2 in 0,30 ure za norelgestromin in etinilestradiol.
English: The improvement in fasting glucose was sustained through the longest study duration of 104 weeks.
Slovenian: Izboljšanje glukoze na tešče se je ohranilo vse do 104. tedna, kolikor je trajala najdaljša študija.
English: Potentially immune-mediated injection site adverse events (e.g., rash, erythema) were reported in 0.7 % of patients and were usually mild.
Slovenian: O potencialno imunskih reakcijah na mestu injiciranja (npr. izpuščaj, eritem) so poročali pri 0,7 % bolnikov in so bile običajno blage.
English: To optimise the insulin glargine dose, both groups were titrated to a target fasting serum glucose of <5.6 mmol/L.
Slovenian: Za optimizacijo odmerka insulina glargina sta bili obe skupini titrirani na ciljno serumsko glukozo na tešče < 5,6 mmol/l.
English: In clinical studies, treatment with dulaglutide was associated with a 1.6 % incidence of treatment emergent dulaglutide anti-drug antibodies, indicating that the structural modifications in the GLP-1 and modified IgG4 parts of the dulaglutide molecule, together with high homology with native GLP-1 and native IgG4, minimise the risk of immune response against dulaglutide.
Slovenian: V kliničnih študijah je bilo zdravljenje z dulaglutidom povezano z 1,6% incidenco protiteles proti dulaglutidu, nastalih med zdravljenjem, kar kaže na to, da strukturne modifikacije v GLP-1 in modificiranih delih IgG4 molekule dulaglutida skupaj z visoko homolognostjo z naravnim GLP-1 in naravnim IgG4 zmanjšujejo tveganje za odziv imunskega sistema na dulaglutid.
English: Table 1: The frequency of adverse reactions of dulaglutide
Slovenian: Preglednica 1: Pogostnost neželenih učinkov dulaglutida
English: If pancreatitis is confirmed, dulaglutide should not be restarted.
Slovenian: Če je pankreatitis potrjen, se zdravljenja z dulaglutidom ne sme znova uvesti.
English: In all studies, dulaglutide produced clinically significant improvements in glycaemic control as measured by glycosylated haemoglobin A1c (HbA1c).
Slovenian: V vseh študijah je dulaglutid povzročil klinično pomembna izboljšanja v glikemični urejenosti, merjeni z glikoziliranim hemoglobinom A1c (HbA1c).
English: No cases of severe hypoglycaemia were observed for Trulicity or placebo.
Slovenian: Primerov hude hipoglikemije pri zdravilu Trulicity ali pri placebu niso opazili.
English: At baseline, overall mean eGFR was 38 mL/min/1.73 m2, 30% of patients had eGFR < 30 mL/min/1.73 m2.
Slovenian: V izhodišču je skupni mediani eGFR znašal 38 ml/min/1,73 m2, 30 % bolnikov pa je imelo eGFR < 30 ml/min/1,73 m2.
English: If a dose is missed, it should be administered as soon as possible if there are at least 3 days (72 hours) until the next scheduled dose.
Slovenian: V primeru zamujenega odmerka je treba odmerek dati čimprej, če manjkajo vsaj 3 dnevi (72 ur) do naslednjega predpisanega odmerka.
English: Kaplan-Meier plot of time to first occurrence of the composite outcome: CV death, non-fatal myocardial infarction or non-fatal stroke, in the dulaglutide long-term cardiovascular outcome study
Slovenian: Kaplan-Meierjeva krivulja časa do prvega pojava sestavljenega izida: KV-smrti, miokardnega infarkta brez smrtnega izida ali možganske kapi brez smrtnega izida, v dolgoročni študiji kardiovaskularnega izida z dulaglutidom
English: If you use Trulicity in combination with a sulphonylurea or insulin, low blood sugar (hypoglycaemia) may occur which may reduce your ability to concentrate.
Slovenian: Če uporabljate zdravilo Trulicity v kombinaciji s sulfonilsečnino ali insulinom, lahko pride do nizkega krvnega sladkorja (hipoglikemija), ki lahko zmanjša vašo sposobnost koncentracije.
English: 3 INJECT
Slovenian: 3 INJICIRAJTE
English: If you use more Trulicity than you should
Slovenian: Če ste uporabili večji odmerek zdravila Trulicity, kot bi smeli
English: In clinical trials, acute pancreatitis has been reported in association with dulaglutide (see section 4.8).
Slovenian: kliničnih preskušanjih so o akutnem pankreatitisu poročali v povezavi z dulaglutidom (glejte poglavje 4.8).